FDA accepts SDI's PMA

The FDA accepted for filing a PMA from Spectral Diagnostics (TSE:SDI) subsidiary Sepsis (Toronto, Ontario) for its gram negative endotoxin assay. The completion of the PMA submission triggered a $2.5 ...